#FINEHEART
Finerenone gets the HFpEF nod from FDA - as expected

NephJC coverage of FINEHEARTS www.nephjc.com/news/fineheart

Our editorial on kidney outcomes from FINEARTS: pubmed.ncbi.nlm.nih.gov/39814475/
Re”FINE”ing the role of non steroidal MRAs in Cardio Kidney Metabolic syndrome — NephJC
This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FID...
www.nephjc.com
July 14, 2025 at 6:40 PM
and yes i can and will call iago
fineheart a manic pixie dream girl.
April 12, 2025 at 5:24 PM
2/ Before we start, just take a look at #nephjc discussions on FINe-HEART pooled analysis

<a href="http://www.nephjc.com/news/fineheart" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">http://www.nephjc.com/news/fineheart

✍️And the critical commentary on MRAs in CKD by the moderator @hswapnil

#KidneyWk
November 16, 2024 at 6:10 PM
This #FINEHEART pooled analysis, published in #JACC, demonstrated that finerenone significantly reduced the risk of new-onset atrial fibrillation/atrial flutter across the CKM spectrum. www.jacc.org/doi/10.1016/... #AFib
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis
www.jacc.org
April 30, 2025 at 6:19 PM
Gironde : FineHeart autorisée à tester sa mini-pompe pour insuffisance cardiaque sur des patients en France
🔗https://l.sudouest.fr/QiG
June 6, 2025 at 11:27 AM
Up next on #NephJC
➡️Join us on Oct 8/9 for a “fine” discussion on the kidney cardio metabolic axis !
We’ll breakdown “FINEHEART” for all the geeks out there !🫶
t.co/2mYfefqBxh

See you soon !

Tweetorial by @DrPallaviPrasad
https://www.nature.com/articles/s41591-024-03264-4
t.co
October 7, 2024 at 1:22 PM
FineHeart Receives Slovenia JAZMP (Agency for Medicinal Products and Medical Devices of the Republic of Slovenia) Authorization to Launch Its FIH Clinical Study on Patients Suffering From Advanced Heart Failure

https://www.europesays.com/2211071/

  BORDEAUX, France & LJUBLJANA, …
FineHeart Receives Slovenia JAZMP (Agency for Medicinal Products and Medical Devices of the Republic of Slovenia) Authorization to Launch Its FIH Clinical Study on Patients Suffering From Advanced Heart Failure - EUROPE SAYS
BORDEAUX, France & LJUBLJANA, Slovenia--(BUSINESS WIRE)--FineHeart S.A., a clinical-stage medical technology company specializing in the development of
www.europesays.com
July 2, 2025 at 8:30 AM
9/10 For more #NephJC details check out:

✅VA by @KajareeG

✅Spanish VA by @drmiliflores

✅#NephJC summary by @MdhAz09 www.nephjc.com/news/fineheart
October 22, 2024 at 7:17 PM
⏰ 60 min to #NephJC

Lights, camera, nephro-action! FIDELIO brings the drama, FIGARO steals the show, and FIDELITY proves it’s no one-hit wonder. Finerenone isn’t just the FINEHEART of kidney protection, it might be the full-blown blockbuster.
👇See FINE❤️recap
www.nephjc.com/news/...
Re”FINE”ing the role of non steroidal MRAs in Cardio Kidney Metabolic syndrome — NephJC
This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FIDELIO-DKD trial?
www.nephjc.com
July 9, 2025 at 12:00 AM